A review of public information. No hands-on testing, laboratory inspection or medical review is claimed.
Included does not mean cancel-anytime
Ivím advertises compounded semaglutide from $149 and tirzepatide from $224 per month, including medication and the program fee. The same page says medication is prescribed and shipped according to the selected program length and cancellation is unavailable once the program starts.
Sources: Ivím — individualized GLP-1 program, FDA — compounding questions and answers
Outcome claims need context
The provider page discusses its published results and compares them with another published study. It explicitly says that comparison is not a head-to-head trial. We do not convert it into a claim that Ivím outperforms another service or medication for a given person.
Sources: Ivím — individualized GLP-1 program, FDA — compounding questions and answers
Our assessment
Included program pricing is helpful, but the public starting figure alone does not establish the full initial charge or every future cost. Request the exact commitment, pharmacy, strength and payment schedule. This review assesses public commercial terms, not the quality of medical care.
Sources: Ivím — individualized GLP-1 program, FDA — compounding questions and answers
Every offer in our file.
Compounded semaglutide program
Compounded prescriptionAdvertised starting price includes medication and program fee. Program duration determines prescribing and shipping; the page says cancellation is unavailable once the program starts.
Compounded tirzepatide program
Compounded prescriptionAdvertised starting price includes medication and program fee. Program duration determines prescribing and shipping; the page says cancellation is unavailable once the program starts.
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Ivím — individualized GLP-1 program ↗
Official public information; price and terms checked October 8, 2026.
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.